Avibactam/ceftazidimeDevelopment of resistance in KPC-producing Klebsiella pneumoniae infection: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1792卷 / 1期
关键词：
D O I：
10.1007/s40278-020-75155-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 47
相关论文
共 50 条
  • [31] A Post-Neurosurgical Infection due to KPC-Producing Klebsiella pneumoniae Treated with Meropenem-Vaborbactam: A Case Report
    Choi, Seohyun
    Fedorenko, Marianna
    Lin-Torre, Janet
    Mistry, Nirav
    Smoke, Steven
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 1041 - 1043
  • [32] In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae
    Gaibani, Paolo
    Ambretti, Simone
    Viale, PierLuigi
    Re, Maria Carla
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (05) : 1457 - 1459
  • [33] Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
    Kitchel, Brandon
    Rasheed, J. Kamile
    Endimiani, Andrea
    Hujer, Andrea M.
    Anderson, Karen F.
    Bonomo, Robert A.
    Patel, Jean B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4201 - 4207
  • [34] In Vitro Activity of Ceftazidime/Avibactam Alone and in Combination With Fosfomycin and Carbapenems Against KPC-producing Klebsiella Pneumoniae
    Romanelli, Federica
    De Robertis, Annalisa
    Carone, Gianluca
    Dalfino, Lidia
    Stufano, Monica
    Del Prete, Raffaele
    Mosca, Adriana
    NEW MICROBIOLOGICA, 2020, 43 (03): : 136 - 138
  • [35] Changes in KPC-producing Klebsiella pneumoniae susceptibility from the pre- to ceftazidime-avibactam era
    Boattini, Matteo
    Bianco, Gabriele
    Comini, Sara
    Iannaccone, Marco
    Casale, Roberto
    Charrier, Lorena
    Cavallo, Rossana
    Costa, Cristina
    INFECTIOUS DISEASES, 2022, 54 (04) : 311 - 313
  • [36] Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-Producing Klebsiella pneumoniae Bacteremia and Renal Impairment
    Veillette, John J.
    Truong, James
    Forland, Steven C.
    PHARMACOTHERAPY, 2016, 36 (11): : E172 - E177
  • [37] Impact of renal-adjusted ceftazidime/avibactam in patients with KPC-producing Klebsiella pneumoniae bloodstream infection: a retrospective cohort study
    Oliva, A.
    Volpicelli, L.
    Gigante, A.
    Di Nillo, M.
    Trapani, S.
    Viscido, A.
    Sacco, F.
    Mastroianni, C. M.
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (06):
  • [38] Emergence of transferable ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae due to a novel CMY AmpC β-lactamase in China
    Xu, Min
    Zhao, Jun
    Xu, Li
    Yang, Qing
    Xu, Hao
    Kong, Haishen
    Zhou, Jianying
    Fu, Yiqi
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (01) : 136.e1 - 136.e6
  • [39] Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
    Goettig, Stephan
    Frank, Denia
    Mungo, Eleonora
    Nolte, Anika
    Hogardt, Michael
    Besier, Silke
    Wichelhaus, Thomas A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (11) : 3211 - 3216
  • [40] Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients
    Gaibani, Paolo
    Bovo, Federica
    Bussini, Linda
    Bartoletti, Michele
    Lazzarotto, Tiziana
    Viale, Pierluigi
    Pea, Federico
    Ambretti, Simone
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (05) : 654.e1 - 654.e4
12345